O'Shaughnessy Asset Management’s Pacira BioSciences PCRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,606	Closed	-$217K	–	1340
2021 Q4	$217K	Hold	3,606	–	–	﹤0.01%	1024
2021 Q3	$202K	Sell	3,606 -1,104	-23%	-$63.6K	﹤0.01%	1040
2021 Q2	$286K	Sell	4,710 -10	-0.2%	-$633	0.01%	876
2021 Q1	$331K	Sell	4,720 -36	-0.8%	-$2.57K	0.01%	742
2020 Q4	$285K	Buy	4,756 +409	+9%	+$23.9K	0.01%	708
2020 Q3	$262K	Buy	+4,347	New	+$253K	0.01%	620

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

O'Shaughnessy Asset Management's PCRX Position: Q1 2022 in Review

O'Shaughnessy Asset Management sold out of Pacira BioSciences (PCRX) in Q1 2022, closing a stake of 3,606 shares — an estimated $217K sold.

O'Shaughnessy Asset Management first reported a position in PCRX in Q3 2020 and held it in 6 quarters. The position peaked at $331K in Q1 2021. 301 funds tracked by Wall St. Rank hold PCRX as of Q1 2022.

O'Shaughnessy Asset Management reported no remaining Pacira BioSciences position as of Q1 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 3,606 Pacira BioSciences shares in Q1 2022, an estimated $217K.
O'Shaughnessy Asset Management first reported a position in Pacira BioSciences in Q3 2020 and held it in 6 quarters.
O'Shaughnessy Asset Management's Pacira BioSciences position peaked at $331K in Q1 2021.
301 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2022, filed 13 May 2022.